Onyx (ONXX) Stock Has M&A 'Baked In'; Deutsche Bank Cuts to Hold
Tweet Send to a Friend
Deutsche Bank downgraded Onyx Pharmaceuticals (NASDAQ: ONXX) from Buy to Hold with a price target of $140.00 (from $110.00). Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE